 Tzu Phang
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 4 | 2017 | 129 | 0.410 |
Why?
| | Gene Expression Profiling | 15 | 2014 | 1777 | 0.410 |
Why?
| | Software | 5 | 2013 | 680 | 0.390 |
Why?
| | Databases, Genetic | 3 | 2009 | 238 | 0.350 |
Why?
| | Gene Expression Regulation | 9 | 2017 | 2601 | 0.340 |
Why?
| | Mammary Glands, Animal | 3 | 2006 | 128 | 0.280 |
Why?
| | Chorionic Gonadotropin | 5 | 2000 | 78 | 0.270 |
Why?
| | Alternative Splicing | 1 | 2009 | 248 | 0.260 |
Why?
| | Receptors, LH | 4 | 2000 | 9 | 0.250 |
Why?
| | Nuclear Proteins | 3 | 2017 | 740 | 0.240 |
Why?
| | Oligonucleotide Array Sequence Analysis | 12 | 2014 | 751 | 0.230 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2017 | 83 | 0.230 |
Why?
| | Face | 3 | 2017 | 175 | 0.200 |
Why?
| | Computational Biology | 4 | 2013 | 669 | 0.190 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 124 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 254 | 0.160 |
Why?
| | Precancerous Conditions | 1 | 2021 | 166 | 0.150 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 25 | 0.150 |
Why?
| | Dog Diseases | 2 | 2012 | 106 | 0.150 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.150 |
Why?
| | Precision Medicine | 1 | 2024 | 461 | 0.150 |
Why?
| | Respiratory System | 2 | 2017 | 150 | 0.140 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 64 | 0.140 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 910 | 0.140 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 387 | 0.140 |
Why?
| | Database Management Systems | 2 | 2009 | 51 | 0.140 |
Why?
| | Systems Biology | 2 | 2017 | 68 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2012 | 1450 | 0.130 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.130 |
Why?
| | Proteins | 3 | 2000 | 1023 | 0.130 |
Why?
| | Maxillofacial Development | 1 | 2017 | 20 | 0.130 |
Why?
| | Airway Remodeling | 1 | 2017 | 63 | 0.130 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2017 | 153 | 0.120 |
Why?
| | Cluster Analysis | 4 | 2010 | 501 | 0.120 |
Why?
| | Mesoderm | 1 | 2017 | 147 | 0.120 |
Why?
| | Photoaffinity Labels | 3 | 2000 | 6 | 0.120 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 86 | 0.110 |
Why?
| | DNA Copy Number Variations | 2 | 2021 | 188 | 0.110 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.110 |
Why?
| | Proline Oxidase | 1 | 2015 | 6 | 0.110 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 331 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2017 | 139 | 0.110 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 395 | 0.110 |
Why?
| | Gene Expression | 3 | 2016 | 1478 | 0.110 |
Why?
| | Response Elements | 1 | 2015 | 86 | 0.110 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.110 |
Why?
| | Transcription Factor AP-2 | 1 | 2014 | 82 | 0.110 |
Why?
| | Dogs | 3 | 2012 | 478 | 0.100 |
Why?
| | Gene Dosage | 1 | 2014 | 145 | 0.100 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1482 | 0.100 |
Why?
| | Cleft Lip | 1 | 2014 | 73 | 0.100 |
Why?
| | Lactation | 2 | 2006 | 193 | 0.100 |
Why?
| | Internet | 2 | 2009 | 693 | 0.100 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2668 | 0.100 |
Why?
| | Transcription, Genetic | 3 | 2015 | 1454 | 0.100 |
Why?
| | Cleft Palate | 1 | 2014 | 91 | 0.100 |
Why?
| | Cell Line | 6 | 2016 | 2823 | 0.100 |
Why?
| | Gene Regulatory Networks | 3 | 2013 | 318 | 0.090 |
Why?
| | Introns | 1 | 2014 | 256 | 0.090 |
Why?
| | Antiporters | 2 | 2003 | 22 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2019 | 1166 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2016 | 1135 | 0.090 |
Why?
| | NF-kappa B | 2 | 2014 | 667 | 0.090 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 30 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 478 | 0.090 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 12 | 0.090 |
Why?
| | Iodine Radioisotopes | 5 | 2000 | 138 | 0.090 |
Why?
| | Mice | 12 | 2021 | 18358 | 0.090 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 141 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 979 | 0.080 |
Why?
| | Animals | 17 | 2021 | 38106 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 457 | 0.080 |
Why?
| | Immunity, Innate | 3 | 2012 | 835 | 0.080 |
Why?
| | Comparative Genomic Hybridization | 1 | 2010 | 28 | 0.080 |
Why?
| | Databases, Nucleic Acid | 1 | 2010 | 38 | 0.080 |
Why?
| | Transcriptome | 2 | 2017 | 1042 | 0.080 |
Why?
| | Philadelphia Chromosome | 1 | 2010 | 18 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 159 | 0.080 |
Why?
| | Genomics | 2 | 2024 | 830 | 0.080 |
Why?
| | Down-Regulation | 2 | 2010 | 618 | 0.080 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 68 | 0.080 |
Why?
| | NFATC Transcription Factors | 1 | 2010 | 94 | 0.080 |
Why?
| | Influenza A virus | 1 | 2011 | 119 | 0.080 |
Why?
| | Reoviridae | 1 | 2010 | 38 | 0.080 |
Why?
| | Dexamethasone | 3 | 2017 | 365 | 0.080 |
Why?
| | Adenoma | 1 | 2012 | 218 | 0.080 |
Why?
| | Encephalitis, Viral | 1 | 2010 | 45 | 0.070 |
Why?
| | Reoviridae Infections | 1 | 2010 | 54 | 0.070 |
Why?
| | Wnt Proteins | 1 | 2010 | 133 | 0.070 |
Why?
| | Alcohol-Related Disorders | 1 | 2010 | 121 | 0.070 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 128 | 0.070 |
Why?
| | Breeding | 1 | 2009 | 63 | 0.070 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 287 | 0.070 |
Why?
| | Humans | 28 | 2024 | 145785 | 0.070 |
Why?
| | Algorithms | 2 | 2009 | 1851 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 778 | 0.070 |
Why?
| | Biomarkers, Tumor | 2 | 2012 | 1329 | 0.070 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 151 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2010 | 373 | 0.060 |
Why?
| | Data Collection | 1 | 2010 | 643 | 0.060 |
Why?
| | RNA Polymerase II | 3 | 2017 | 350 | 0.060 |
Why?
| | Blood Platelets | 1 | 2010 | 379 | 0.060 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2883 | 0.060 |
Why?
| | Pregnenolone Carbonitrile | 1 | 2006 | 2 | 0.060 |
Why?
| | Receptors, Steroid | 1 | 2006 | 42 | 0.060 |
Why?
| | Models, Statistical | 1 | 2010 | 672 | 0.060 |
Why?
| | Up-Regulation | 2 | 2006 | 848 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2003 | 968 | 0.060 |
Why?
| | Influenza, Human | 1 | 2012 | 624 | 0.060 |
Why?
| | Sleep | 1 | 2013 | 889 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2008 | 588 | 0.060 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 12 | 0.060 |
Why?
| | Inflammation | 2 | 2014 | 2885 | 0.050 |
Why?
| | RNA, Messenger | 6 | 2010 | 2805 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2008 | 467 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 414 | 0.050 |
Why?
| | Calcium | 1 | 2010 | 1192 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 574 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1507 | 0.050 |
Why?
| | Lung | 2 | 2010 | 4116 | 0.050 |
Why?
| | Mutagenesis | 3 | 2002 | 194 | 0.050 |
Why?
| | Models, Biological | 3 | 2012 | 1764 | 0.050 |
Why?
| | Protein Binding | 3 | 2016 | 2240 | 0.050 |
Why?
| | Transcription Factors | 2 | 2009 | 1736 | 0.050 |
Why?
| | Alcoholism | 1 | 2010 | 826 | 0.050 |
Why?
| | Signal Transduction | 6 | 2015 | 5226 | 0.050 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5995 | 0.050 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 13 | 0.050 |
Why?
| | Pregnancy, Animal | 1 | 2003 | 51 | 0.050 |
Why?
| | Cells, Cultured | 4 | 2017 | 4151 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2006 | 529 | 0.050 |
Why?
| | Cell Membrane | 2 | 2006 | 709 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 118 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 442 | 0.050 |
Why?
| | Tetracycline Resistance | 1 | 2002 | 2 | 0.050 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2003 | 53 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 52 | 0.050 |
Why?
| | Binding Sites | 4 | 2015 | 1311 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 102 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 428 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2021 | 29 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2003 | 2131 | 0.040 |
Why?
| | Female | 14 | 2021 | 79045 | 0.040 |
Why?
| | Mitochondria | 1 | 2008 | 994 | 0.040 |
Why?
| | Brain | 2 | 2013 | 2969 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 2171 | 0.040 |
Why?
| | Liver | 2 | 2006 | 1899 | 0.040 |
Why?
| | Blotting, Western | 2 | 2016 | 1184 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 4090 | 0.040 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2022 | 202 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2022 | 364 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 534 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 178 | 0.040 |
Why?
| | Chemokines | 2 | 2012 | 217 | 0.040 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 66 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 527 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 1217 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2019 | 31 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 849 | 0.040 |
Why?
| | Apoptosis | 3 | 2014 | 2445 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1043 | 0.030 |
Why?
| | Breast Neoplasms | 2 | 2009 | 2393 | 0.030 |
Why?
| | Promoter Regions, Genetic | 2 | 2015 | 1247 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4568 | 0.030 |
Why?
| | Haplotypes | 1 | 2019 | 500 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 335 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 206 | 0.030 |
Why?
| | Jaw | 1 | 2017 | 27 | 0.030 |
Why?
| | Hypertrophy | 1 | 2017 | 128 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2017 | 132 | 0.030 |
Why?
| | Tongue | 1 | 2017 | 77 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2017 | 172 | 0.030 |
Why?
| | Nose | 1 | 2017 | 67 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2017 | 277 | 0.030 |
Why?
| | Adenoviridae | 1 | 2017 | 199 | 0.030 |
Why?
| | Pregnancy | 3 | 2006 | 7216 | 0.030 |
Why?
| | Acetic Acid | 1 | 1996 | 16 | 0.030 |
Why?
| | Autoradiography | 1 | 1996 | 66 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1996 | 106 | 0.030 |
Why?
| | Acetates | 1 | 1996 | 78 | 0.030 |
Why?
| | Hypoxia | 1 | 2003 | 1199 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 88 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2014 | 2514 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 474 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 666 | 0.030 |
Why?
| | Exons | 2 | 2010 | 364 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 475 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2014 | 318 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4556 | 0.020 |
Why?
| | Bronchi | 1 | 2015 | 263 | 0.020 |
Why?
| | Prognosis | 2 | 2012 | 4330 | 0.020 |
Why?
| | Education | 1 | 2013 | 105 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2003 | 1331 | 0.020 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.020 |
Why?
| | Cytokines | 2 | 2012 | 2069 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 981 | 0.020 |
Why?
| | Enkephalins | 1 | 2013 | 21 | 0.020 |
Why?
| | Cartilage | 1 | 2014 | 198 | 0.020 |
Why?
| | Prealbumin | 1 | 2013 | 37 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 83 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 132 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 396 | 0.020 |
Why?
| | Protein Precursors | 1 | 2013 | 136 | 0.020 |
Why?
| | Models, Molecular | 3 | 2003 | 1599 | 0.020 |
Why?
| | Lectins, C-Type | 1 | 2012 | 59 | 0.020 |
Why?
| | Male | 8 | 2013 | 73012 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2010 | 3551 | 0.020 |
Why?
| | Protein Structure, Secondary | 2 | 2003 | 371 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2014 | 372 | 0.020 |
Why?
| | Bone and Bones | 1 | 2014 | 318 | 0.020 |
Why?
| | Exome | 1 | 2013 | 229 | 0.020 |
Why?
| | DNA Mutational Analysis | 2 | 2003 | 410 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2016 | 532 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 896 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 322 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 337 | 0.020 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 19 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 26 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 770 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 89 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 322 | 0.020 |
Why?
| | Middle Aged | 5 | 2012 | 36309 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 106 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2010 | 77 | 0.020 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.020 |
Why?
| | Phagocytosis | 1 | 2012 | 296 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 615 | 0.020 |
Why?
| | Dasatinib | 1 | 2010 | 58 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2011 | 98 | 0.020 |
Why?
| | Markov Chains | 1 | 2010 | 132 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 194 | 0.020 |
Why?
| | Amino Acid Motifs | 2 | 2000 | 219 | 0.020 |
Why?
| | Demography | 1 | 2010 | 282 | 0.020 |
Why?
| | ras Proteins | 1 | 2010 | 150 | 0.020 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 45 | 0.020 |
Why?
| | Thiazoles | 1 | 2010 | 142 | 0.020 |
Why?
| | Fibroblasts | 1 | 2015 | 1028 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1857 | 0.020 |
Why?
| | Quality Control | 1 | 2009 | 161 | 0.020 |
Why?
| | Amino Acid Substitution | 2 | 2000 | 302 | 0.020 |
Why?
| | Benzamides | 1 | 2010 | 226 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2009 | 45 | 0.020 |
Why?
| | Cyclosporine | 1 | 2010 | 256 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2006 | 2525 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 309 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 234 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 74 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 284 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 383 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2008 | 203 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 887 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1568 | 0.020 |
Why?
| | Interferons | 1 | 2010 | 186 | 0.020 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 14 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 451 | 0.020 |
Why?
| | S100 Proteins | 1 | 2008 | 35 | 0.020 |
Why?
| | Ethanol | 1 | 2013 | 631 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 638 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 638 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1475 | 0.020 |
Why?
| | Cell Communication | 1 | 2009 | 327 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 375 | 0.020 |
Why?
| | Tamoxifen | 1 | 2008 | 193 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 368 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 719 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 598 | 0.020 |
Why?
| | Pyrimidines | 1 | 2010 | 530 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 1074 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1165 | 0.010 |
Why?
| | Phenotype | 1 | 2014 | 3170 | 0.010 |
Why?
| | Rats | 2 | 2006 | 5585 | 0.010 |
Why?
| | Adult | 4 | 2012 | 40882 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1430 | 0.010 |
Why?
| | Time Factors | 2 | 2009 | 7134 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2008 | 337 | 0.010 |
Why?
| | Chromatin | 1 | 2009 | 553 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 154 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 838 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2009 | 563 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 381 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 404 | 0.010 |
Why?
| | Dietary Fats | 1 | 2006 | 308 | 0.010 |
Why?
| | Research Design | 1 | 2011 | 1139 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17330 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2008 | 729 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1723 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1477 | 0.010 |
Why?
| | Sequence Analysis, Protein | 1 | 2003 | 32 | 0.010 |
Why?
| | Milk Proteins | 1 | 2003 | 33 | 0.010 |
Why?
| | Osteopontin | 1 | 2003 | 35 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2011 | 2050 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 121 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2003 | 157 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 12 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 72 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 107 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2008 | 883 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2865 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 6033 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 160 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3418 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2192 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 373 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2002 | 563 | 0.010 |
Why?
| | Cysteine | 1 | 2002 | 211 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 855 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1969 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2399 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2000 | 244 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2000 | 208 | 0.010 |
Why?
| | Tyrosine | 1 | 2000 | 217 | 0.010 |
Why?
| | Serine | 1 | 2000 | 143 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 392 | 0.010 |
Why?
| | Lipids | 1 | 2003 | 707 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 8347 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 835 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 938 | 0.010 |
Why?
| | Aged | 2 | 2011 | 26217 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2003 | 1129 | 0.010 |
Why?
| | Antibodies | 1 | 1998 | 397 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 14254 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2003 | 1957 | 0.010 |
Why?
| | Adolescent | 1 | 2003 | 22577 | 0.000 |
Why?
| | Child | 1 | 2003 | 22740 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|